Crohn's & Colitis Foundation of America Elects Five New Trustees

NEW YORK, March 31, 2016 /PRNewswire-USNewswire/ -- The Crohn's & Colitis Foundation of America (CCFA) is pleased to welcome Donald Kortz, Mark Murray, PhD, Marcy Nanus, Joseph Nemmers, and Robert "Van" Pulley as new members of CCFA's National Board of Trustees through 2019. CCFA's National Board of Trustees oversees the control and management of the policies, practices, principles, affairs, funds, and property of the organization. Trustees are elected to the Board for three-year terms and may serve no more than two consecutive terms.

"I am pleased to welcome Don, Mark, Marcy, Joe, and Van to the Crohn's & Colitis Foundation of America's National Board of Trustees. These five professionals bring a wide range of skills, experiences, and vision to CCFA, and will bring new ideas and energy to the organization as we move into our 50th year," said CCFA's National Board Chair Vance Gibbs.

Don Kortz is the Vice Chairman of Cushman & Wakefield in Denver, Colorado. Dr. Mark Murray serves as Arbutus's Chief Executive Officer and Director and resides in Seattle, Washington. Marcy Nanus is Senior Vice President of the Trout Group in New York. Scottsdale, Arizona resident Joe Nemmers is an advisor to Warburg Pincus and chairman of Accriva Diagnostics. Robert "Van" Pulley resides in McLean, Virginia and recently retired after a 28-year career with the World Bank.

"Volunteers are the lifeblood of CCFA and are hand-selected to join our leadership based on their commitment to accomplishing our vision of a future free of Crohn's disease and ulcerative colitis. Don, Mark, Marcy, Joe, and Van are representative of the incredibly passionate and dedicated individuals who support the organization and without whom we wouldn't be where we are today- closer to cures than ever," said Michael Osso, CCFA's President & CEO.

Over the past five decades, CCFA has built major momentum toward its mission of curing Crohn's disease and ulcerative colitis, and improving the lives of children and adults affected by IBD. Increased giving has raised critical revenue enabling CCFA to develop multidisciplinary research initiatives, including programs targeting the microbiome and genetic contributors to IBD, as well as to expand its patient and professional education programs.

About the Crohn's & Colitis Foundation of America
The Crohn's & Colitis Foundation of America (CCFA) is the largest non-profit, voluntary, health organization dedicated to finding cures for inflammatory bowel diseases (IBD). CCFA's mission is to cure Crohn's disease and ulcerative colitis, and to improve the quality of life of children and adults who suffer from these diseases. The Foundation works to fulfill its mission by funding research; providing educational resources for patients and their families, medical professionals, and the public; and furnishing supportive services for those afflicted with IBD. For more information visit www.ccfa.org, call 888-694-8872, or email [email protected].

SOURCE Crohn's & Colitis Foundation of America

Related Links

http://www.ccfa.org